SCHEMBL27950964

SCHEMBL27950964

Cc1nc(Nc2nc(-c3ccc(CO)cc3)cc(N3CCC(O)CC3)n2)sc1C(=O)O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE5A O76074 6/20 0.62
▸ CCNT1 O60563 1/20 0.39
▸ CDK4 P11802 1/20 0.39
▸ CCND1 P24385 1/20 0.39
▸ CDK9 P50750 1/20 0.39
▸ CDK6 Q00534 1/20 0.39
▸ CDK11A Q9UQ88 1/20 0.39
▸ HRH1 P35367 3/20 0.36
▸ HRH4 Q9H3N8 3/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ HPGD P15428 1/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ HRH2 P25021 1/20 0.36
▸ HRH3 Q9Y5N1 1/20 0.36
▸ IKBKB O14920 1/20 0.36
▸ ACACB O00763 2/20 0.35
▸ ACACA Q13085 2/20 0.35
▸ FGFR1 P11362 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27937605 0.92 PDE5A (0.59) PDE5ACCNT1CDK4CCND1CDK9
SCHEMBL292060 0.91 PDE5A (0.77) PDE5AALDH1A1HPGDNPC1KDM4E
SCHEMBL27937575 0.90 PDE5A (0.60) PDE5ACCNT1CDK4CCND1CDK9
SCHEMBL27950936 0.90 PDE5A (0.59) PDE5ACCNT1CDK4CCND1CDK9
SCHEMBL26647596 0.89 PDE5A (0.58) PDE5ACCNT1CDK4CCND1CDK9
SCHEMBL27937612 0.89 PDE5A (0.64) PDE5ACCNT1CDK4CCND1CDK9
SCHEMBL27950930 0.87 PDE5A (0.61) PDE5ACCNT1CDK4CCND1CDK9
SCHEMBL27937611 0.87 PDE5A (0.71) PDE5AALDH1A1HPGDNPC1KDM4E
SCHEMBL27950958 0.86 PDE5A (0.56) PDE5ACCNT1CDK4CCND1CDK9
SCHEMBL290787 0.85 PDE5A (0.74) PDE5AALDH1A1HPGDNPC1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103547267-A Treatment of addiction and impulse control disorders using PDE7 inhibitors OMEROS CORP 2014-01-29 — — CN disclosed
Send feedback